| dc.contributor.author | Fontana, E | |
| dc.contributor.author | Valeri, N | |
| dc.date.accessioned | 2019-11-18T12:02:47Z | |
| dc.date.issued | 2019-12-01 | |
| dc.identifier.citation | Clinical cancer research : an official journal of the American Association for Cancer Research, 2019, 25 (23), pp. 6896 - 6898 | |
| dc.identifier.issn | 1078-0432 | |
| dc.identifier.uri | https://repository.icr.ac.uk/handle/internal/3422 | |
| dc.identifier.eissn | 1557-3265 | |
| dc.identifier.doi | 10.1158/1078-0432.ccr-19-2732 | |
| dc.description.abstract | Different classes of BRAF mutations are present in colorectal and other cancers. Non-V600 mutations are rare; however, their detection rate will increase as the use of next-generation sequencing ramps up quickly in clinical practice. Different biochemical signaling pathways are active in non-V600 BRAF-mutant cancers and may affect treatment response.See related article by Yaeger et al., p. 7089. | |
| dc.format | Print-Electronic | |
| dc.format.extent | 6896 - 6898 | |
| dc.language | eng | |
| dc.language.iso | eng | |
| dc.publisher | AMER ASSOC CANCER RESEARCH | |
| dc.rights.uri | https://www.rioxx.net/licenses/under-embargo-all-rights-reserved | |
| dc.subject | Humans | |
| dc.subject | Colonic Neoplasms | |
| dc.subject | Rectal Neoplasms | |
| dc.subject | Proto-Oncogene Proteins B-raf | |
| dc.subject | Mutation | |
| dc.subject | ErbB Receptors | |
| dc.title | Class(y) Dissection of BRAF Heterogeneity: Beyond Non-V600. | |
| dc.type | Journal Article | |
| dcterms.dateAccepted | 2019-10-01 | |
| rioxxterms.versionofrecord | 10.1158/1078-0432.ccr-19-2732 | |
| rioxxterms.licenseref.uri | https://www.rioxx.net/licenses/under-embargo-all-rights-reserved | |
| rioxxterms.licenseref.startdate | 2019-12 | |
| rioxxterms.type | Journal Article/Review | |
| dc.relation.isPartOf | Clinical cancer research : an official journal of the American Association for Cancer Research | |
| pubs.issue | 23 | |
| pubs.notes | Not known | |
| pubs.organisational-group | /ICR | |
| pubs.organisational-group | /ICR/Primary Group | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Molecular Pathology | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Molecular Pathology/Gastrointestinal Cancer Biology and Genomics | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Molecular Pathology/Systems and Precision Cancer Medicine | |
| pubs.organisational-group | /ICR/Students | |
| pubs.organisational-group | /ICR/Students/PhD and MPhil | |
| pubs.organisational-group | /ICR/Students/PhD and MPhil/16/17 Starting Cohort | |
| pubs.organisational-group | /ICR | |
| pubs.organisational-group | /ICR/Primary Group | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Molecular Pathology | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Molecular Pathology/Gastrointestinal Cancer Biology and Genomics | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Molecular Pathology/Systems and Precision Cancer Medicine | |
| pubs.organisational-group | /ICR/Students | |
| pubs.organisational-group | /ICR/Students/PhD and MPhil | |
| pubs.organisational-group | /ICR/Students/PhD and MPhil/16/17 Starting Cohort | |
| pubs.publication-status | Published | |
| pubs.volume | 25 | |
| pubs.embargo.terms | Not known | |
| icr.researchteam | Gastrointestinal Cancer Biology and Genomics | |
| icr.researchteam | Systems and Precision Cancer Medicine | |
| dc.contributor.icrauthor | Fontana, Elisa | |
| dc.contributor.icrauthor | Valeri, Nicola | |
